Newsroom | 5521 results

Sorted by: Latest

Radiology
-

Verasonics Appoints New Senior Vice President, Research & Development

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics names Richard Van Bibber, Ph.D. as SVP of R&D. He will lead ultrasound research innovation and advance product development strategy....
-

UNC Health Launches UNC Health Ventures, Marking Next Phase of Strategic Investment Platform

CHAPEL HILL, N.C.--(BUSINESS WIRE)--UNC Health Launches UNC Health Ventures...
-

QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today issued a mid-year 2026 letter to shareholders from its CEO, Dr. Raluca Dinu. The full text of the letter appears below and at this link which can be found on the QT Imaging website. Dear Fellow Shareholders, I am energized by QT Imaging’s many accomplishme...
-

bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies enters distribution agreement with AvMEDICAL to expand CyPath Lung sales reach and access to government healthcare systems....
-

OncoOne Establishes Scientific Advisory Board to Support its Modular PreTarg-it® Platform for Radionuclide Therapies

VIENNA--(BUSINESS WIRE)--OncoOne, a biotechnology company utilizing its expert knowledge in antibody engineering to support the further growth of targeted radiopharmaceutical therapies globally, announced their new Scientific Advisory Board (SAB) members whose collective expertise spans foundational research, translational medicine and scientific collaborations. The interdisciplinary guidance from the SAB will be instrumental in advancing and broadening the company’s PreTarg-it®, a modular plat...
-

Ionetix Appoints Paul Surdez as Head of Investor Relations

LANSING, Mich.--(BUSINESS WIRE)--Ionetix Corporation ("Ionetix" or the "Company"), a manufacturer of proprietary superconducting cyclotrons and producer of medical isotopes for diagnostic imaging and targeted alpha therapy, today announced the appointment of Paul Surdez as Head of Investor Relations. Mr. Surdez brings more than 25 years of investor relations and corporate communications leadership, including senior investor relations roles at S&P 500 healthcare companies. The appointment fo...
-

Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments

GEORGETOWN, Texas--(BUSINESS WIRE)--Radiation Detection Company (RDC), the world's longest-operating providers of occupational dosimetry services, today announced the launch of Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures. Built specifically to reduce staff radiation exposure in environments such as cardiac catheterization laboratories, interventional...
-

ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. Second Quarter 2026 and Recent Highlights On June 25, 2026, ENDRA entered into a definitive merger agreement with ASP Isotopes Inc. (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , R...
-

QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holding, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and six months ended June 30, 2026, and provided a business update. “Our second quarter results demonstrate continued execution and the growing commercial momentum of QT Imaging. Revenue more than doubled year-over-y...
-

Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, congratulates Dr. Erica Schwartz on her confirmation as director of the Centers for Disease Control and Prevention (CDC). Dr. Schwartz has served as a member of Butterfly Network's Board of Directors since 2021 and has stepped down from the Board effective August 5, 2026 in advance of assuming her n...